91 related articles for article (PubMed ID: 2868945)
1. Post-operative chemotherapy for ovarian carcinoma: a prospective study with cyclophosphamide.
Akinkugbe A; Uguru VE; Mordi VP
Int J Gynaecol Obstet; 1985 Dec; 23(6):499-504. PubMed ID: 2868945
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide and cisplatinum combination chemotherapy for the treatment of epithelial ovarian carcinoma.
Hahn K; Magrina JF; Masterson BJ
Int J Gynaecol Obstet; 1985 Dec; 23(6):509-13. PubMed ID: 2868947
[TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
4. The treatment of advanced ovarian carcinoma (II): interval reassessment operations during chemotherapy.
Heintz AP; Van Oosterom AT; Trimbos JB; Schaberg A; Van der Velde E; Nooy M
Gynecol Oncol; 1988 Jul; 30(3):359-71. PubMed ID: 2968942
[No Abstract] [Full Text] [Related]
5. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for stage III epithelial carcinoma of the ovary.
Coltart RS; Nethersell AB; Brown CH
Gynecol Oncol; 1986 Jan; 23(1):105-10. PubMed ID: 3510945
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
[TBL] [Abstract][Full Text] [Related]
8. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
9. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
10. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
11. Ovarian epithelial tumors of low malignant potential.
Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
[TBL] [Abstract][Full Text] [Related]
12. Treatment of epithelial ovarian carcinoma by surgical debulking followed by single alkylating agent chemotherapy.
Hanson MB; Powell DE; Donaldson ES; van Nagell JR
Gynecol Oncol; 1980 Dec; 10(3):337-42. PubMed ID: 7461498
[No Abstract] [Full Text] [Related]
13. Advanced ovarian cancer: primary treatment with surgery, radiotherapy, and chemotherapy.
Griffiths CT; Grogan RH; Hall TC
Cancer; 1972 Jan; 29(1):1-7. PubMed ID: 5007381
[No Abstract] [Full Text] [Related]
14. Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
Morgan RJ; Doroshow JH; Leong L; Schriber J; Shibata S; Forman S; Hamasaki V; Margolin K; Somlo G; Alvarnas J; McNamara M; Longmate J; Raschko J; Chow W; Vasilev S; McGonigle K; Yen Y
Bone Marrow Transplant; 2001 Nov; 28(9):859-63. PubMed ID: 11781646
[TBL] [Abstract][Full Text] [Related]
15. [Stage III and IV epithelial cancer of the ovary. Prognostic role of surgical tumor reduction].
Le Bouedec G; Ben Ahmed S; Plagne R; Dauplat J
Presse Med; 1990 Mar; 19(11):506-10. PubMed ID: 2138748
[TBL] [Abstract][Full Text] [Related]
16. [An evaluation of two postoperative chemotherapy protocols in ovarian common epithelial cancer: a comparison of continuous and intermittent hospitalization].
Sakamoto H; Suzuki H; Hayakawa S; Kiseki Y; Miyakawa Y; Ohkubo Y; Watanabe Y; Takami M; Kashiwazaki K; Tanaka H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1491-4. PubMed ID: 2584826
[No Abstract] [Full Text] [Related]
17. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
18. [The value of platinum dose intensity in first-line therapy on subsequent disease follow-up of epithelial ovarian carcinoma].
Gruböck K
Wien Klin Wochenschr; 1994; 106(11):362-6. PubMed ID: 8053205
[No Abstract] [Full Text] [Related]
19. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
20. Surgery for common epithelial tumors of the ovary.
Wharton JT; Herson J
Cancer; 1981 Jul; 48(2 Suppl):582-9. PubMed ID: 7023667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]